Lv3
220 积分 2023-04-27 加入
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial
2天前
已完结
The effects of anti‐obesity medications on bone metabolism: A critical appraisal
4天前
已完结
A molecular recognition paradigm: promiscuity associated with the ligand-receptor interactions of the activin members of the TGF-β superfamily
4天前
已完结
Peptide Antibodies: Current Status
6天前
已完结
Antibody engineering and its therapeutic applications
6天前
已完结
Antibody engineering and its therapeutic applications
6天前
已关闭
Model‐Informed Drug Development of the Masked Anti‑PD‑L1 Antibody CX‐072
6天前
已完结
RNA Interference With Zilebesiran for Mild to Moderate Hypertension
6天前
已完结
Balancing weight and muscle loss in GLP1 receptor agonist therapy
9天前
已完结
LC–MS/MS Multiplexed Assay for The Quantitation of A Therapeutic Protein BMS-986089 and The Target Protein Myostatin
9天前
已完结
皖公网安备34019202002308
